Ki67 is a promising molecular target in the diagnosis of cancer (Review)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Scholzen, 2000, The Ki-67 protein: from the known and the unknown, J Cell Physiol, 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
Shirendeb, 2009, Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar, Acta Histochem Cytochem, 42, 181, 10.1267/ahc.09030
Hooghe, 2008, ConTra: a promoter alignment analysis tool for identification of transcription factor binding sites across species, Nucleic Acids Res, 36, W128, 10.1093/nar/gkn195
Modlin, 2008, Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors, J Natl Cancer Inst, 100, 1282, 10.1093/jnci/djn275
Klöppel, 2004, The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification, Ann N Y Acad Sci, 1014, 13, 10.1196/annals.1294.002
Brown, 2002, Ki67 protein: the immaculate deception?, Histopathology, 40, 2, 10.1046/j.1365-2559.2002.01343.x
Ishihara, 2013, Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival, Oncology, 84, 135, 10.1159/000345321
Sorbye, 2012, Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas, PLoS One, 7, e47068, 10.1371/journal.pone.0047068
Sorbye, 2012, Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas, BMC Clin Pathol, 12, 7, 10.1186/1472-6890-12-7
Ciancio, 2012, Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer, Multidiscip Respir Med, 7, 29, 10.1186/2049-6958-7-29
Josefsson, 2012, Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance, Scand J Urol Nephrol, 46, 247, 10.3109/00365599.2012.669791
Iatropoulos, 1996, Proliferation markers, Exp Toxicol Pathol, 48, 175, 10.1016/S0940-2993(96)80039-X
Jacquemier, 1998, Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis, J Pathol, 184, 130, 10.1002/(SICI)1096-9896(199802)184:2<130::AID-PATH19>3.0.CO;2-W
Kausch, 2003, Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo, Int J Cancer, 105, 710, 10.1002/ijc.11111
Liu, 2012, Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell, Cancer Sci, 103, 1880, 10.1111/j.1349-7006.2012.02380.x
Gerlach, 1997, Ki-67 expression during rat liver regeneration after partial hepatectomy, Hepatology, 26, 573, 10.1002/hep.510260307
Le Guellec, 2011, Neoadjuvant treatment of breast cancer: implications for the pathologist, Ann Pathol, 31, 442, 10.1016/j.annpat.2011.10.003
Yerushalmi, 2010, Ki67 in breast cancer: prognostic and predictive potential, Lancet Oncol, 11, 174, 10.1016/S1470-2045(09)70262-1
Duchrow, 1996, Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67, Cell Prolif, 29, 1, 10.1111/j.1365-2184.1996.tb00090.x
Halm, 2000, Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett’s esophagus, Hepatogastroenterology, 47, 962
Rahmanzadeh, 2007, Chromophore-assisted light inactivation of pKi67 leads to inhibition of ribosomal RNA synthesis, Cell Prolif, 40, 422, 10.1111/j.1365-2184.2007.00433.x
Castro, 2010, Long-term effects of nifedipine on human gingival epithelium: a histopathological and immunohistochemical study, J Oral Sci, 52, 55, 10.2334/josnusd.52.55
Panteva, 2011, Direct observations of shifts in the β-sheet register of a protein-peptide complex using explicit solvent simulations, Biophys J, 100, L50, 10.1016/j.bpj.2011.03.035
Tian, 2011, A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression, Tumour Biol, 32, 273, 10.1007/s13277-010-0119-4
Chen, 2012, IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation, Tumour Biol, 33, 2217, 10.1007/s13277-012-0483-3
Nakano, 2010, Current advancement in radiation therapy for uterine cervical cancer, J Radiat Res, 51, 1, 10.1269/jrr.09132
Kim, 2013, Usefulness of Ki-67 (MIB-1) immunostaining in the diagnosis of pulmonary sclerosing hemangiomas, APMIS, 121, 105, 10.1111/j.1600-0463.2012.02945.x
Steels, 2001, Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis, Eur Respir J, 18, 705, 10.1183/09031936.01.00062201
Martin, 2004, Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis, Br J Cancer, 91, 2018, 10.1038/sj.bjc.6602233
Faes, 2012, Chorangiocarcinoma of the placenta: a case report and clinical review, Placenta, 33, 658, 10.1016/j.placenta.2012.04.012
Almeida, 2007, Prognostic value of morphologic and clinical parameters in pT2 – pT3 prostate cancer, Int Braz J Urol, 33, 662, 10.1590/S1677-55382007000500007
Vaira, 2010, Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors, Proc Natl Acad Sci USA, 107, 8352, 10.1073/pnas.0907676107
Hofman, 2012, Changing paradigms with molecular imaging of neuroendocrine tumors, Discov Med, 14, 71
Laurinavicius, 2014, A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue, Breast Cancer Res, 16, R35, 10.1186/bcr3639
Hayashi, 2012, Ki67 immunohistochemical staining: the present situation of diagnostic criteria, Nihon Rinsho, 7, 428
Zizi-Sermpetzoglou, 2012, Atypical polypoid adenomyoma of the uterus. A case report and a review of the literature, Eur J Gynaecol Oncol, 33, 118
Zini, 2011, Contemporary management of adrenocortical carcinoma, Eur Urol, 60, 1055, 10.1016/j.eururo.2011.07.062
Viale, 2011, Pathological work up of the primary tumor: getting the proper information out of it, Breast, 20, S82, 10.1016/S0960-9776(11)70300-9
Leong, 2011, The changing role of pathology in breast cancer diagnosis and treatment, Pathobiology, 78, 99, 10.1159/000292644
Ibrahim, 2013, Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: Clinical impact, Oncology, 84, 150, 10.1159/000345795
Chlebowski, 2002, American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition, J Clin Oncol, 20, 3328, 10.1200/JCO.2002.06.029
Blancato, 2004, Correlation of amplification and overexpression of the c-myc oncogene in high grade breast cancer: FISH, in situ hybridization and immunohistochemical analysis, Br J Cancer, 90, 1612, 10.1038/sj.bjc.6601703
Jonat, 2011, Is the Ki-67 labelling index ready for clinical use?, Ann Oncol, 22, 500, 10.1093/annonc/mdq732
Sapino, 2006, Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure, Virchows Arch, 449, 288, 10.1007/s00428-006-0233-2
Camp, 2008, A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers, J Clin Oncol, 26, 5630, 10.1200/JCO.2008.17.3567
Konsti, 2011, Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer, BMC Clin Pathol, 11, 3, 10.1186/1472-6890-11-3
Klimowicz, 2012, Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma, Eur J Cancer, 48, 2166, 10.1016/j.ejca.2012.04.010
Sánchez-Navarro, 2010, Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues, Biotechniques, 48, 389, 10.2144/000113388
Farragher, 2008, RNA expression analysis from formalin fixed paraffin embedded tissues, Histochem Cell Biol, 130, 435, 10.1007/s00418-008-0479-7
Mittempergher, 2011, Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue, PLoS One, 6, e17163, 10.1371/journal.pone.0017163
Karamitopoulou, 1998, Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas, Hum Pathol, 29, 140, 10.1016/S0046-8177(98)90224-6
Geyer, 2012, Molecular classification of estrogen receptor-positive/luminal breast cancers, Adv Anat Pathol, 19, 39, 10.1097/PAP.0b013e31823fafa0
Claudio, 2002, Expression of Cell-Cycle-regulated Proteins pRb2/p130, p107, p27kip1, p53, mdm-2, and Ki-67 (MIB-1) in Prostatic Gland Adenocarcinoma1, Clin Cancer, 8, 1808
Hu, 2012, Clinical significance of Smac and Ki-67 expression in pancreatic cancer, Hepato-gastroenterology, 59, 2640
McCormick, 1993, Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB-1, Histopathology, 22, 355, 10.1111/j.1365-2559.1993.tb00135.x
Merkel, 1987, Flow cytometry, cellular DNAcontent, and prognosis in human malignancy, J Clin Oncol, 5, 1690, 10.1200/JCO.1987.5.10.1690
Clark, 1992, Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients, J Clin Oncol, 10, 428, 10.1200/JCO.1992.10.3.428
Fernandez, 1994, Proliferating cellnuclear antigen expression to predict occult disease in clinical stage Inonseminomatous testicular germ cell tumors, J Urol, 152, 1133, 10.1016/S0022-5347(17)32522-3
de Aguiar, 2010, Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role?. A critical review, Neurol Res, 32, 1060, 10.1179/016164110X12670144737855
Prayson, 2005, The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms, Adv Anat Pathol, 12, 144, 10.1097/01.pap.0000163957.21409.52
Lind-Landström, 2012, Prognostic value of histological features in diffuse astrocytomas WHO grade II, Int J Clin Exp Pathol, 5, 152
Nabi, 2008, Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma, J Ayub Med Coll Abbottabad, 20, 44
Hegazy, 2014, Role of Ki-67, P53 and Bcl-2 in Advanced Colorectal Carcinoma, Academic Journal of Cancer Research, 7, 168
Inwald, 2013, Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry, Breast Cancer Res Treat, 139, 539, 10.1007/s10549-013-2560-8
Klöppel, 2004, The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification, Ann NY Acad Sci, 1014, 13, 10.1196/annals.1294.002
Morimoto, 2008, Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas, Endocr J, 55, 49, 10.1507/endocrj.K07-079
Gupta, 2010, Functional biomarkers in cervical precancer: an overview, Diagn Cytopathol, 38, 618, 10.1002/dc.21270
Jalava, 2006, Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index, Histopathology, 48, 674, 10.1111/j.1365-2559.2006.02402.x
Zhang, 2011, Neoadjuvant endocrine therapy for postmenopausal estrogen receptor-positive patients with breast cancer, Zhonghua Zhong Liu Za Zhi, 33, 241
Gentile, 2006, Detection of human papillomavirus DNA, p53 and ki-67 expression in penile carcinomas, Int J Immunopathol Pharmacol, 19, 209, 10.1177/205873920601900121
Kroeze, 2010, Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma, Cancer Biomark, 7, 261, 10.3233/CBM-2010-0195
Yu, 2002, RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells, Proc Natl Acad Sci USA, 99, 6047, 10.1073/pnas.092143499
Li, 2004, A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death, Science, 305, 1471, 10.1126/science.1098231
Ben-Izhak, 2002, Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma, Histopathology, 41, 519, 10.1046/j.1365-2559.2002.01444.x
Hu, 2012, Clinical significance of Smac and Ki-67 expression in pancreatic cancer, Hepatogastroenterology, 59, 2640
Liu, 2012, Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC), Lung Cancer, 77, 176, 10.1016/j.lungcan.2012.03.001
Golmohammadi, 2012, The prognostic value of the P53 protein and the Ki67 marker in breast cancer patients, J Pak Med Assoc, 62, 871
Tihan, 2000, Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas, Arch Pathol Lab Med, 124, 108, 10.5858/2000-124-0108-PVOKAP
Iamaroon, 2004, Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma, J Oral Pathol Med, 33, 30, 10.1111/j.1600-0714.2004.00192.x
Boonyaphiphat, 2012, The prognostic value of p53, Bcl-2 and Bax expression in laryngeal cancer, J Med Assoc Thai, 95, 1317
Tadbir, 2012, Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors, Asian Pac J Cancer Prev, 13, 5155, 10.7314/APJCP.2012.13.10.5155
Chen, 2012, A novel molecular grading model: combination of Ki67 and VEGF in predicting tumor recurrence and progression in non-invasive urothelial bladder cancer, Asian Pac J Cancer Prev, 13, 2229, 10.7314/APJCP.2012.13.5.2229
Hoogerbrugge, 2012, Tumour examination to detect hereditary colorectal cancer, Ned Tijdschr Geneeskd, 156, A4982
Nabi, 2008, Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma, J Ayub Med Coll Abbottabad, 20, 44
Tvedskov, 2012, Staging of women with breast cancer after introduction of sentinel node guided axillary dissection, Dan Med J, 59, B4475
Wang, 2011, p53 regulates Ki-67 promoter activity through p53-and Sp1-dependent manner in HeLa cells, Tumour Biol, 32, 905, 10.1007/s13277-011-0191-4
Grala, 2009, New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas, Folia Histochem Cytobiol, 47, 587
Tuominen, 2010, ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67, Breast Cancer Res, 12, R56, 10.1186/bcr2615
Gilles, 2008, Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study, Pediatr Dev Pathol, 11, 108, 10.2350/07-06-0303.1
Grzybicki, 2001, Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors, Cancer, 92, 2720, 10.1002/1097-0142(20011115)92:10<2720::AID-CNCR1626>3.0.CO;2-Z
Hsu, 2003, Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods, Mod Pathol, 16, 951, 10.1097/01.MP.0000084631.64279.BC
Walker, 2006, Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment I, Histopathology, 49, 406, 10.1111/j.1365-2559.2006.02514.x
Bertucci, 2013, Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients, Ann Oncol, 24, 625, 10.1093/annonc/mds510
Nielsen, 2012, Automated quantification of MART1-verified Ki67 indices by digital image analysis in melanocytic lesions, Arch Pathol Lab Med, 136, 627, 10.5858/arpa.2011-0360-OA
Nielsen, 2011, Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions, Am J Dermatopathol, 33, 361, 10.1097/DAD.0b013e3182120173
Petit, 2004, Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy, Eur J Cancer, 40, 205, 10.1016/S0959-8049(03)00675-0
Chang, 2000, Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma, Cancer, 89, 2145, 10.1002/1097-0142(20001201)89:11<2145::AID-CNCR1>3.0.CO;2-S
Viale, 2008, Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1–98 comparing adjuvant tamoxifen with letrozole, J Clin Oncol, 26, 5569, 10.1200/JCO.2008.17.0829
Yerushalmi, 2010, Ki67 in breast cancer: prognostic and predictive potential, Lancet Oncol, 11, 174, 10.1016/S1470-2045(09)70262-1
Park, 2013, Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma, Int J Gynecol Cancer, 23, 81, 10.1097/IGC.0b013e3182738361
Nagao, 2011, Ki67 and BUBR1 may discriminate clinically insignificant prostate cancer in the PSA range <4 ng/ml, Jpn J Clin Oncol, 41, 555, 10.1093/jjco/hyq233
Machowska, 2014, Nuclear location of tumor suppressor protein maspin inhibits proliferation of breast cancer cells without affecting proliferation of normal epithelial cells, BMC Cancer, 14, 142, 10.1186/1471-2407-14-142
Nielsen, 2013, Proliferation indices of phosphor-histone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma, Mod Pathol, 26, 404, 10.1038/modpathol.2012.188
Vogt, 2013, Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression, Histopathology, 62, 334, 10.1111/his.12009
Palmqvist, 1999, Low tumour cell proliferation at the invasive marginis associated with a poor prognosis in Dukes’ stage B colorectal cancers, Br J Cancer, 79, 577, 10.1038/sj.bjc.6690091
Kimura, 2000, Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer, Int J Oncol, 16, 55
Holdcraft, 1969, Malignant melanomas of the nasal and paranasal sinus mucosa, Ann Otol Rhinol Laryngol, 78, 5, 10.1177/000348946907800101
Rinaldo, 2001, Primary mucosal melanoma of the nasal cavity and paranasal sinuses, Acta Otolaryngol, 121, 979, 10.1080/000164801317166907
Bisgaard, 2007, Young age colorectal cancer and identification of hereditary non-polyposis colorectal cancer cohorts, Br J Surg, 94, 1055, 10.1002/bjs.5949
Niezabitowski, 1999, Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study, J Surg Oncol, 70, 150, 10.1002/(SICI)1096-9098(199903)70:3<150::AID-JSO2>3.0.CO;2-Z
Tuleta, 2010, Apoptosis-regulated survival of primarily extravascular cells in proliferative active poststent neointima, Cardiovasc Pathol, 19, 353, 10.1016/j.carpath.2009.07.006
Wajed, 2001, DNA methylation: an alternative pathway to cancer, Ann Surg, 234, 10, 10.1097/00000658-200107000-00003
Zheng, 2006, Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells, Life Sci, 78, 724, 10.1016/j.lfs.2005.05.064
Zheng, 2005, Anti-Ki-67 peptide nucleic acid affects the proliferation and apoptosis of human renal carcinoma cells in vitro, Life Sci, 76, 1873, 10.1016/j.lfs.2004.10.034
Chan, 2006, Antisense oligonucleotides: from design to therapeutic application, Clin Exp Pharmacol Physiol, 33, 533, 10.1111/j.1440-1681.2006.04403.x
Paulasova, 2004, The peptide nucleic acids (PNAs): a new generation of probes for genetic and cytogenetic analyses, Ann Genet, 47, 349, 10.1016/j.anngen.2004.07.001
Smolina, 2003, Sequence-universal recognition of duplex DNA by oligonucleotides via pseudocomplementarity and helix invasion, Chem Biol, 10, 591, 10.1016/S1074-5521(03)00150-9
Demidov, 2004, Two sides of the coin: affinity and specificity of nucleic acid interactions, Trends Biochem Sci, 29, 62, 10.1016/j.tibs.2003.12.007
Demidov, 1994, Stability of peptide nucleic acids in human serum and cellular extracts, Biochem Pharmacol, 48, 1310, 10.1016/0006-2952(94)90171-6
Tuschl, 2001, RNA interference and small interfering RNAs, Chembiochem, 2, 239, 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R
Zheng, 2009, Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA, Cancer Gene Ther, 16, 20, 10.1038/cgt.2008.61
Pai, 2006, Prospects of RNA interference therapy for cancer, Gene Ther, 13, 464, 10.1038/sj.gt.3302694
Brummelkamp, 2002, A system for stable expression of short interfering RNAs in mammalian cells, Science, 296, 550, 10.1126/science.1068999
Lieberman, 2003, Interfering with disease: opportunities and roadblocks to harnessing RNA interference, Trends Mol Med, 9, 397, 10.1016/S1471-4914(03)00143-6
Moore, 2010, Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown, Methods Mol Biol, 629, 141
Zhu, 2005, Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells, Mol Cancer Ther, 4, 451, 10.1158/1535-7163.MCT-04-0162
Starborg, 1996, The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression, J Cell Sci, 109, 143, 10.1242/jcs.109.1.143